| J0897 | Injection, denosumab, 1 mg | 8,520 | $20 | $153.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 1,030 | $130 | $137.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,320 | $80 | $100.5K |
| J9155 | Injection, degarelix, 1 mg | 5,040 | $1 | $15.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 280 | $50 | $14.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 150 | $70 | $10.7K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 740 | $10 | $5.9K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 230 | $20 | $4.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 40 | $100 | $3.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $90 | $3.9K |